Literature DB >> 7204561

Peripheral metabolism of intact parathyroid hormone. Role of liver and kidney and the effect of chronic renal failure.

K A Hruska, A Korkor, K Martin, E Slatopolsky.   

Abstract

The plasma disappearance rate (metabolic clearance rate) of administered intact parathyroid hormone (intact PTH) was analyzed in awake dogs with indwelling hepatic and renal vein catheters. The metabolic clearance rate (MCR) of intact PTH was found to be very rapid, 21.6 +/- 3.1 ml/min per kg in 11 normal dogs. The liver accounted for the greatest fraction of the MCR of intact PTH (61 +/- 4%) by virtue of an arterial minus venous (a - v) difference across the liver of 45 +/- 3%. The renal uptake of intact PTH accounted for 31 +/- 3% of the MCR of intact PTH. The renal a - v difference for intact PTH of 29 +/- 2% was significantly greater than the filtration fraction indicating renal uptake of intact PTH at sites independent of glomerular filtration. Together, the hepatic and renal clearances of intact PTH accounted for all but a small fraction of the MCR of intact PTH. The MCR of intact PTH, rendered biologically inactive by oxidation, was markedly decreased to 8.8 +/- 1 ml/min per kg. The a - v difference of oxidized intact PTH was reduced both in the liver and kidney. These data suggested that the high uptake rates of intact PTH are dependent, at least in part, upon sites recognizing only biologically active PTH. Chronic renal failure (CRF) decreased the MCR of intact PTH to 11.3 +/- 1.3 ml/min per kg (n = 10). Both the hepatic and renal a - v differences of intact PTH were reduced in dogs with CRF. This resulted in reductions in the hepatic and renal clearances of intact PTH. These studies identify the liver as a major extrarenal site of PTH metabolism affected by CRF. They suggest that CRF impairs the function of the major uptake sites involved in intact PTH metabolism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7204561      PMCID: PMC370640          DOI: 10.1172/jci110106

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

Review 1.  Metabolism of parathyroid hormone: physiologic and clinical significance.

Authors:  G V Segre; H D Niall; J F Habener; J T Potts
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

2.  Studies on the role of the liver in the metabolism of parathyroid hormone. I. Effects of partial hepatectomy and incubation of the hormone with tissue homogenates.

Authors:  V S Fang; A H Tashjian
Journal:  Endocrinology       Date:  1972-05       Impact factor: 4.736

3.  Immunoreactive parathyroid hormone in circulation of man.

Authors:  J F Habener; G V Segre; D Powell; T M Murray; J T Potts
Journal:  Nat New Biol       Date:  1972-08-02

4.  Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1.

Authors:  J M Canterbury; E Reiss
Journal:  Proc Soc Exp Biol Med       Date:  1972-09

5.  Parathyroid extract-induced changes in the oxidation of citrate, succinate and other organic acids by liver.

Authors:  D V Cohn; F D Griffith; R Levy
Journal:  Endocrinology       Date:  1965-10       Impact factor: 4.736

6.  Structural basis of biological and immunological activity of parathyroid hormone.

Authors:  J T Potts; G D Aurbach; L M Sherwood; A Sandoval
Journal:  Proc Natl Acad Sci U S A       Date:  1965-12       Impact factor: 11.205

7.  Studies on the biosynthesis in vitro of parathyroid hormone. II. The effect of calcium and magnesium on synthesis of parathyroid hormone isolated from bovine parathyroid tissue and incubation medium.

Authors:  J W Hamilton; F W Spierto; R R MacGregor; D V Cohn
Journal:  J Biol Chem       Date:  1971-05-25       Impact factor: 5.157

8.  Heterogeneity of parathyroid hormone. Clinical and physiologic implications.

Authors:  R Silverman; R S Yalow
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

9.  Metabolism of proinsulin, insulin, and C-peptide in the rat.

Authors:  A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Binding of parathyroid hormone to bovine kidney-cortex plasma membranes.

Authors:  H S Sutcliffe; T J Martin; J A Eisman; R Pilczyk
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

View more
  16 in total

1.  Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis.

Authors:  Xia Liu; Fang Zhong; Xu-long Tang; Fu-lin Lian; Qiao Zhou; Shan-mai Guo; Jia-fu Liu; Peng Sun; Xu Hao; Ying Lu; Wei-ming Wang; Nan Chen; Nai-xia Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-03-17       Impact factor: 6.150

2.  Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism.

Authors:  Daniel Seehofer; Nada Rayes; Jochen Klupp; Thomas Steinmüller; Frank Ulrich; Christian Müller; Ralph Schindler; Ulrich Frei; Peter Neuhaus
Journal:  Langenbecks Arch Surg       Date:  2005-02-22       Impact factor: 3.445

Review 3.  Receptor-mediated endocytosis.

Authors:  P Stahl; A L Schwartz
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism.

Authors:  Theresia Weber; Martin Zeier; Ulf Hinz; Tobias Schilling; Markus W Büchler
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

Review 5.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

6.  Structural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic adenosine monophosphate and bone gamma-carboxyglutamic acid-containing protein from perfused rat hindquarters.

Authors:  M S Calvo; M J Fryer; K J Laakso; R A Nissenson; P A Price; T M Murray; H Heath
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

7.  Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia.

Authors:  K Olgaard; M Arbelaez; J Schwartz; S Klahr; E Slatopolsky
Journal:  Calcif Tissue Int       Date:  1982-07       Impact factor: 4.333

8.  Development of a highly sensitive and specific two-site enzyme immunoassay for parathyroid hormone (1-34): application to pharmacokinetic study on intranasal parathyroid hormone (1-34) in human.

Authors:  T Kohno; N Murasugi; H Sakurai; K Watabe; H Nakamuta; M Koida; Y Sugie; M Nomura; A Yanagawa
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

9.  Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.

Authors:  D Haffner; F Schaefer; J Girard; E Ritz; O Mehls
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 10.  Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels.

Authors:  Dieter Haffner; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2019-12-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.